Literature DB >> 18635872

The best medicine: exercise training normalizes chemosensitivity and sympathoexcitation in heart failure.

Michael K Stickland1, Jordan D Miller.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18635872      PMCID: PMC2536822          DOI: 10.1152/japplphysiol.90889.2008

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


× No keyword cloud information.
  14 in total

1.  Carotid chemoreceptor modulation of sympathetic vasoconstrictor outflow during exercise in healthy humans.

Authors:  Michael K Stickland; Barbara J Morgan; Jerome A Dempsey
Journal:  J Physiol       Date:  2008-01-17       Impact factor: 5.182

2.  Peripheral chemoreceptor hypersensitivity: an ominous sign in patients with chronic heart failure.

Authors:  P Ponikowski; T P Chua; S D Anker; D P Francis; W Doehner; W Banasiak; P A Poole-Wilson; M F Piepoli; A J Coats
Journal:  Circulation       Date:  2001-07-31       Impact factor: 29.690

3.  The effects of inspiratory intrathoracic pressure production on the cardiovascular response to submaximal exercise in health and chronic heart failure.

Authors:  Jordan D Miller; Curtis A Smith; Sarah J Hemauer; Jerome A Dempsey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-09-22       Impact factor: 4.733

4.  Carotid chemoreceptor modulation of regional blood flow distribution during exercise in health and chronic heart failure.

Authors:  Michael K Stickland; Jordan D Miller; Curtis A Smith; Jerome A Dempsey
Journal:  Circ Res       Date:  2007-04-12       Impact factor: 17.367

5.  Cardiac sympathetic afferent stimulation augments the arterial chemoreceptor reflex in anesthetized rats.

Authors:  Lie Gao; Yan-Xia Pan; Wei-Zhong Wang; Yu-Long Li; Harold D Schultz; Irving H Zucker; Wei Wang
Journal:  J Appl Physiol (1985)       Date:  2006-08-10

6.  Heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): design and rationale.

Authors:  David J Whellan; Christopher M O'Connor; Kerry L Lee; Steven J Keteyian; Lawton S Cooper; Stephen J Ellis; Eric S Leifer; William E Kraus; Dalane W Kitzman; James A Blumenthal; David S Rendall; Nancy Houston-Miller; Jerome L Fleg; Kevin A Schulman; Ileana L Piña
Journal:  Am Heart J       Date:  2007-02       Impact factor: 4.749

7.  Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure.

Authors:  J N Cohn; T B Levine; M T Olivari; V Garberg; D Lura; G S Francis; A B Simon; T Rector
Journal:  N Engl J Med       Date:  1984-09-27       Impact factor: 91.245

Review 8.  Vascular biology of angiotensin and the impact of physical activity.

Authors:  James W E Rush; Crystal D Aultman
Journal:  Appl Physiol Nutr Metab       Date:  2008-02       Impact factor: 2.665

9.  Exercise training improves peripheral chemoreflex function in heart failure rabbits.

Authors:  Yu-Long Li; Yanfeng Ding; Chad Agnew; Harold D Schultz
Journal:  J Appl Physiol (1985)       Date:  2008-06-26

10.  Exercise training enhances baroreflex sensitivity by an angiotensin II-dependent mechanism in chronic heart failure.

Authors:  Tarek M Mousa; Dongmei Liu; Kurtis G Cornish; Irving H Zucker
Journal:  J Appl Physiol (1985)       Date:  2007-12-13
View more
  3 in total

1.  Assessment for Exercise Prescription in Heart Failure.

Authors:  Marco Guazzi
Journal:  Card Fail Rev       Date:  2015-04

2.  Effects of Strength Training Sessions Performed with Different Exercise Orders and Intervals on Blood Pressure and Heart Rate Variability.

Authors:  Sandro Lemos; Tiago Figueiredo; Silvio Marques; Thalita Leite; Diogo Cardozo; Jeffrey M Willardson; Roberto Simão
Journal:  Int J Exerc Sci       Date:  2018-05-01

3.  Is physical activity associated with resting heart rate in boys and girls? A representative study controlled for confounders.

Authors:  Edner F Zanuto; Raphael M Ritti-Dias; William R Tebar; Catarina C Scarabottolo; Leandro D Delfino; Juliano Casonatto; Luiz Carlos M Vanderlei; Diego Giulliano Destro Christofaro
Journal:  J Pediatr (Rio J)       Date:  2018-12-03       Impact factor: 2.990

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.